about
Small Bowel Bacterial Overgrowth Associated with Persistence of Abdominal Symptoms in Children Treated with a Proton Pump Inhibitor.The mRNA level of the transforming growth factor β1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children.Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population.Prevalence and correlates of vitamin K deficiency in children with inflammatory bowel disease.Small Bowel Bacterial Overgrowth in Children.Demographic characteristics of children with early clinical manifestation of inflammatory bowel disease.Endoscopic therapy of oesophageal strictures in children - a multicentre studyEvaluation of clinical usefulness of serum neopterin determination in children with bacterial infections.The Foker technique (FT) and Kimura advancement (KA) for the treatment of children with long-gap esophageal atresia (LGEA): lessons learned at two European centers.Relations between Leu(5)-enkephalin- (LENK) and VIP-immunoreactive nerve fibres during human drug-resistant colitis. A case study.[Evaluation of enlargement uteroplasty in the treatment of uterine anomalies following exposure to diethylstillbestrol (May 2003)].Long-term proton pump inhibitor therapy leads to small bowel bacterial overgrowth as determined by breath hydrogen and methane excretion.Expression of death receptor 3 on peripheral blood mononuclear cells differes in adult IBD patients and children with newly diagnosed IBD.Evaluation of CD40 and CD80 receptors in the colonic mucosal membrane of children with inflammatory bowel disease.Assessment of induction therapy with infliximab in children with moderate to severe ulcerative colitis: a multi-center study.Indoleamine 2,3-dioxygenase and regulatory t cells in intestinal mucosa in children with inflammatory bowel disease.The association of proton pump inhibitor therapy and small bowel bacterial overgrowth in children.Comparison of fecal pyruvate kinase isoform M2 and calprotectin in assessment of pediatric inflammatory bowel disease severity and activity.Epidemiology of Inflammatory Bowel Disease among Children in PolandModern approach for determination of lactulose, mannitol and sucrose in human urine using HPLC-MS/MS for the studies of intestinal and upper digestive tract permeability.[Hernias of the groin. A new complication of celioscopy][Value and advantages of laparoscopic surgery in the treatment of ectopic pregnancies][Adhesion lysis and removal of an intraperitoneal contraceptive device by celioscopy][Bladder exstrophy and pregnancy]The influence of experimental Bacteroides fragilis infection on substance P and somatostatin-immunoreactive neural elements in the porcine ascending colon - a preliminary report[Tryptase activity in colon mucosal samples of children with inflammatory bowel disease][Bone mineral density in inflammatory bowel diseases in children][Changes in the number of neuroprotective transmitter containing mucosal nerve fibres in children with ulcerative colitis][The case of gastric and ileal bezoar in a 3 year old boy][Analysis of enteral nervous system in children with drug resistant ulcerative colitis][Environmental factors in the etiopathology of inflammatory bowel syndrome][Dysphagia and gastroesophageal reflux in children with oesophageal atresia with tracheo-oesophageal fistula after succesful surgery treatment. Own observations][Inflammatory bowel disease in children--an analysis of the clinical symptoms and selected biochemical parameters][The role of sulphate reducing bacteria in inflammatory bowel disease. A review][Undernutrition in hospitalised children. Part I][Posterior gastric wall ulceration as a complication of percutaneous endoscopic gastrostomy. A report of 2 cases]Helicobacter pylori increases expression of proapoptotic markers Fas and FasL on CD4 lymphocytes in childrenImmunohistochemical distribution of cocaine- and amphetamine-regulated transcript peptide - like immunoreactive (CART-LI) nerve fibers and various degree of co-localization with other neuronal factors in the circular muscle layer of human descendingImmunohistochemical distribution of cocaine and amphetamine regulatory peptide-like immunoreactive (CART-LI) nerve fibers in the circular muscle layer and their relationship to other peptides in the human caecumThe effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial
P50
Q33464192-82E38975-4749-4285-A910-DAB0D3C7F7EDQ36629839-7D1A5619-D15B-4621-8CA0-54B61B8F5B9DQ37529278-9226DAA5-451C-442C-9F7B-022DDBA8978DQ37720524-2E7E5E49-8092-4913-941C-EFAA397FA83CQ38551382-FC7DBAD3-D5AB-45F4-ABA4-D433384B4EC4Q38816412-EF0EB8C6-13FC-4DBC-9072-A76639B02149Q39314644-F5B39BA9-C96E-49A7-A2CB-538425717D40Q41501544-71E2DD83-32BD-4F35-81C7-9BA4BE1F8D50Q43775475-0E066BE8-1D91-4EA5-95D0-FE4F72DFC301Q44679607-A52E8ECE-ECA8-45A6-B04F-8B65B74BB636Q44880572-02FC42EA-DB98-4325-94AA-E9373773ACA6Q47697691-518755CF-EFF7-4C18-B3D7-2A7F2D460916Q48842674-51AF1F59-EF11-43BD-8113-1C95C9586290Q50542471-06F4BF7E-351E-45DA-B835-2A922E93890EQ51017583-6538F249-EFB1-47DB-B983-E1E111E45679Q51088580-B2B66E5C-4986-40E6-98EE-A6876BD41B9AQ54111671-96568662-FBCF-4F41-BDEB-CB3DCB688567Q54367014-191B660C-8A2D-49C6-A260-7508F88DB7B5Q61848888-9E8982AC-B329-4435-AB70-611372711E2AQ64997016-E6C27684-41A1-4A83-95EF-9A7AE80F24BBQ67901036-60359E19-EC5B-42BF-8395-B0184AAAD5A8Q68422841-A0788991-5999-4929-9083-2F48DC6A1D47Q68437852-F01E0F4C-3AAE-4856-8FCF-2C2FF03DA677Q72864571-582FE426-E739-4420-A313-FF47D4A969FDQ79343602-917E9992-6C6A-4805-B819-0B7C764CAC79Q79852182-2BD7F033-0325-4134-ABD9-34DCA9C9DB20Q79852186-15CE4E0F-58FE-4D6E-B763-2C9AE6BABE21Q79852198-967B92D8-94B1-4C5A-9DE0-5C45781138C1Q79852256-D4A90457-A8F4-4A56-B738-F3ACF32F4B16Q80598842-F1448DEC-FC3B-4802-AA52-E025E0E37D8FQ81042078-E4FE3BBA-DB13-4EFD-8154-0E9E03F96BC4Q81590793-922131EC-6754-4C69-AD08-7FBF446B9C77Q81590804-BD1FCBB6-32FE-4B0B-9A48-15A38B7CFC63Q81590808-1F86680E-5961-4D98-B0C9-62738D6DE110Q81681456-C23829E1-667B-4BBA-B05F-616F36A1E78BQ82545044-0BC9EB1F-7AAB-4001-80AA-B166E69C6C37Q84156752-06058A73-1D5E-481D-AEDC-80A75C889DB8Q85818795-136366CE-B0DC-4BF2-B45D-481F734928E1Q88035026-BF0EE954-1AD4-4A3E-B98C-9F2B3B0FC46AQ88345036-3EE86E3A-E12A-4173-AADF-0E1FBC77297D
P50
description
researcher ORCID ID = 0000-0002-4070-4542
@en
wetenschapper
@nl
name
Piotr Landowski
@ast
Piotr Landowski
@en
Piotr Landowski
@es
Piotr Landowski
@nl
Piotr Landowski
@pl
type
label
Piotr Landowski
@ast
Piotr Landowski
@en
Piotr Landowski
@es
Piotr Landowski
@nl
Piotr Landowski
@pl
altLabel
Piotr Paweł Landowski
@pl
prefLabel
Piotr Landowski
@ast
Piotr Landowski
@en
Piotr Landowski
@es
Piotr Landowski
@nl
Piotr Landowski
@pl
P214
P214
P31
P3124
P496
0000-0002-4070-4542
P734
P7859
viaf-311796456